Price transparency
What is disclosed before intake, not a clinical rating.
WeightCare offers online compounded semaglutide and tirzepatide programs with physician messaging and check-ins. Its main comparison challenge is keeping starter, continuing and high-dose supplies separate: a three-month tirzepatide starter is not the same price as its refill or higher-dose program. The public monthly product sections list $399 for semaglutide and $499 for tirzepatide, while longer plans create different dose, payment and refund conditions.
WeightCare does not pay us. We review it so you can compare it with the programs that do. Disclosure
WeightCare publishes its price before the medical intake — you can see what it costs without handing over your health history first.
On this page
WeightCare at a glance
- Price visibility
- Published before intake
- Pharmacy information
- Not publicly named
- Where it operates
- Company advertises limited or treatment-dependent access: Standard plans exclude AK, HI, LA, MS; semaglutide text also excludes AL inconsistently; microdosing/other products differ
The verdict
WeightCare shows a price before the medical intake, but the advertised figure comes with conditions the headline leaves out, or its own terms don't fully back it up. It ranks 247 of 293 on price transparency.
The score beside WeightCare's name rates how much it tells you before the medical intake — the price, the pharmacy and the terms — not how cheap it is.
Considering WeightCare?
Confirm the plan, billing terms and availability before you begin.
What do you get with WeightCare?
- Physician evaluation for prescription weight management, with a medical questionnaire and clinical review rather than medication guaranteed by payment.
- Compounded semaglutide and tirzepatide injection programs offered in monthly and longer-supply plans, with separate high-dose tirzepatide options.
- Consultation, medication if prescribed, delivery, physician messaging and ongoing check-ins described within the program rather than a standalone medicine sale.
- A portal and refill questionnaire for communicating changes in treatment, asking questions and requesting the clinician’s review of the next prescription.
- Optional longer plans and financing choices, which need to be compared by total payment and dose supplied rather than an equivalent monthly number.
- A separate range of microdosing, wellness and coaching products. These have their own eligibility and geography and should not be treated as standard injection-plan inclusions.
How does WeightCare work?
Match the plan to the prescribed dose
The ordinary tirzepatide monthly option and its starter, continuing and high-dose multi-month products cover different doses and supplies. If transferring, provide your current prescription and ask which plan applies now and at refill. Do not select the cheapest starter equivalent if the physician expects a dose outside its included range.
Complete the medical questionnaire
Explain your history, current medicines and weight-management goals to the assigned clinician. Ask how check-ins and messaging operate, what testing is needed and whether the proposed compounded formula is appropriate. The company describes full refunds for medical noncandidates, but the questionnaire is also a significant point in its general voluntary-refund policy.
Confirm the initial and next payments
Request the chosen product, total charge, supply length and renewal in writing. Some pages combine semaglutide content with a shared refill FAQ displaying tirzepatide-style dose examples. Make sure the renewal answer actually names your molecule and dose rather than applying a generic section to every plan. Keep the order confirmation for comparison at refill.
Follow up before renewal or cancellation
WeightCare describes advance renewal notice and a clinical refill questionnaire. Respond with treatment concerns and let the physician determine the next prescription. If you want to stop, cancel through the account or contact support before the next renewal, then save confirmation. Canceling future charges is separate from requesting money back for a prepaid supply.
How much does WeightCare cost?
$399/mo semaglutide product listing; embedded shared renewal FAQ needs molecule-specific clarification; ongoing month-to-month total not established.
$499/mo ordinary compounded injection plan, prescribed doses 2.5–15mg/week; clinical support included. Starter/refill/high-dose prepaid products differ.
Company advertises limited or treatment-dependent access: Standard plans exclude AK, HI, LA, MS; semaglutide text also excludes AL inconsistently; microdosing/other products differ
The product sections list a $399 monthly semaglutide option and a $499 monthly tirzepatide option. Tirzepatide’s three-month starter is $299 per equivalent month, while the published three-month refill is $997 for up to 7.5mg weekly; higher-dose terms cost more. Compare the exact initial and refill order, not a starter equivalent against an unrestricted ongoing plan.
- Semaglutide’s product section lists monthly and longer equivalents, but its embedded shared refill FAQ also shows a $499 renewal figure with tirzepatide-style dose language. Confirm a molecule-specific continuing semaglutide total before relying on $399 as a guaranteed renewal.
- Tirzepatide’s ordinary monthly plan lists $499 and doses from 2.5mg to 15mg weekly. The three-month starter has a narrower titration supply; continuing three-month and higher-dose programs have different totals and included doses.
- The refund policy allows full refunds before submitting the medical questionnaire and for medical noncandidates. After submission, voluntary refunds are generally restricted. Canceling stops future charges but does not automatically refund prior periods or stop paid shipments.
- If a partially shipped longer plan receives an approved refund, delivered medication is valued at the regular comparable shorter-package price. It is not a simple proportional refund at the discounted equivalent, and dispensed medicine cannot be returned.
- General standard-plan guidance excludes Alaska, Hawaii, Louisiana and Mississippi. Some semaglutide product text additionally excludes Alabama, so Alabama applicants should confirm that discrepancy before paying. Microdosing and other treatments have different exclusions.
Considering WeightCare?
Confirm the plan, billing terms and availability before you begin.
Who is WeightCare best for?
A good fit if
- Patients comparing a specific prescribed dose and refill schedule
- People who want physician messaging and regular check-ins
- Shoppers willing to distinguish standard monthly care from starter and high-dose terms
Look elsewhere if
- Patients in excluded states or with unresolved state eligibility
- Anyone treating a starter price as the continuing high-dose cost
- People expecting a simple unused-month refund from a prepaid plan
Considering WeightCare?
Confirm the plan, billing terms and availability before you begin.
What are WeightCare's pros and cons?
Pros
- Product pages describe monthly and different supply choices
- Tirzepatide pricing identifies starter and refill differences
- The refund policy explains how delivered supply is valued
Cons
- Shared FAQ content complicates molecule-specific renewal interpretation
- Higher-dose longer plans differ from advertised starter equivalents
- Refund eligibility narrows early in the intake and fulfillment process
The pharmacy behind the medicine
It does not name its pharmacy. WeightCare does not publicly disclose which compounding pharmacy fills its prescriptions. That is common and it is not an accusation — but it does mean the one thing you would most want to verify about a compounded medicine is the one thing you cannot.
A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program, including the highest-scoring ones.
What is on the public record
FDA warning letter
FDA issued a warning letter to Weightless Medical LLC dba WeightCare in February 2026. It is on the public record in FDA's warning-letter database.
The scoring method includes a deduction for a letter on record. This notice records the agency's letter and its date; funding is disclosed separately.
What else do people ask about WeightCare?
What is the monthly semaglutide price?
The semaglutide product section lists $399 monthly. Its embedded general refill section also displays a $499 renewal amount alongside tirzepatide-style dose examples, so request a written semaglutide-specific renewal quote. Longer-plan equivalents and microdosing products are different purchases; neither should replace a complete continuing-treatment cost.
Does $499 tirzepatide cover higher doses?
The ordinary monthly product description says $499 covers doses from 2.5mg through 15mg weekly when prescribed. Multi-month starter and continuing plans have different included-dose limits and prices. Confirm the clinician’s actual prescription and supply rather than assuming the cheapest multi-month equivalent includes every dose offered in the monthly plan.
What happens after the three-month starter?
The published refill information lists $997 for a three-month supply at up to 7.5mg weekly, with more expensive high-dose options. That is distinct from the three-month starter offer. Ask which dose and total are planned at renewal, particularly if your clinical titration is expected to move beyond the starter range.
Can I cancel and receive a refund?
Canceling stops eligible future charges but does not itself refund an already paid period or stop a paid shipment. The refund policy generally limits voluntary refunds after the medical questionnaire. If a longer-plan refund is approved, supplied medicine is repriced at the comparable regular shorter package before the balance is returned.
What support is included?
WeightCare describes physician consultation, unlimited messaging and regular clinical check-ins alongside medicine and delivery in the program. Confirm your selected order and any separate coaching or laboratory services. The site also sells optional support and wellness products, so the broader catalog should not be assumed to be included in every prescription.
Which states are excluded?
Standard-plan guidance lists Alaska, Hawaii, Louisiana and Mississippi, while some semaglutide text also lists Alabama. Confirm Alabama directly before paying and check the exact product wherever you live. Microdosing, other medicines and pharmacy arrangements can have additional exclusions, so one program’s state list should not be reused for the entire platform.
Sources for this review
Company information and terms used for this review. These sources describe the service; they do not establish treatment outcomes.
How it compares
WeightCare ranks 247 of 293 on our price-transparency score. Every prescription GLP-1 program we review is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.
Because WeightCare shows a price before the intake, it is also ranked on our GLP-1 telehealth ranking and our compounded tirzepatide ranking.
Semaglutide program from $189/mo or $549/quarter; annual-upfront qualification also appears; ongoing month-to-month total not established.Show the full pricing note
GLP-1 program from $299/mo; exact semaglutide formulation, term and ongoing month-to-month total not established.
From $151/mo when purchased quarterly; complete ongoing month-to-month total not established
Brand-name Wegovy pill from $149 plus $149/mo ongoing membership, pen from $199 plus membership
Brand-name Wegovy pill from $149 plus $149/mo ongoing membership, pen from $199 plus membership
Read this before you start
Prices change — confirm on WeightCare's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.